Patents Assigned to The Boards of Trustees of the Leland Stanford Junior University
-
Patent number: 12166098Abstract: Ferroelectric materials and more particularly cerium-doped ferroelectric materials and related devices and methods are disclosed. Aspects of the present disclosure relate to ferroelectric layers of hafnium-zirconium-oxide (HZO) doped with cerium that enable reliable ferroelectric fabrication processes and related structures with significantly improved cycling endurance performance. Such doping in ferroelectric layers also provides the capability to modulate polarization to achieve a desired operation voltage range. Doping concentrations of cerium in HZO films are disclosed with ranges that provide a stabilized polar orthorhombic phase in resulting films, thereby promoting ferroelectric capabilities. Exemplary fabrication techniques for doping cerium in HZO films as well as exemplary device structures including metal-ferroelectric-metal (MFM) and metal-ferroelectric-insulator-semiconductor (MFIS) structures are also disclosed.Type: GrantFiled: November 23, 2021Date of Patent: December 10, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Paul C. McIntyre, Wilman Tsai, John D. Baniecki, Zhouchangwan Yu, Balreen Saini
-
Patent number: 12161510Abstract: Fiber Bragg grating (FBG) sensors are used to provide measurement of chordae tendineae forces. Two basic modes of operation are considered, The first mode is a research mode, where the FBG sensors are affixed to native chordae in situ and preferably in vivo to provide data on chordae forces in a beating heart under various conditions (e.g., normal, hypertensive, etc.), The second mode is a clinical mode, where the FBG sensor can be used to measure tension on a prosthetic neochord during the surgical procedure to implant the prosthesis.Type: GrantFiled: August 28, 2019Date of Patent: December 10, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Michael John Paulsen, Y. Joseph Woo, Mark R. Cutkosky, Jung Hwa Bae, Annabel M. Imbrie-Moore
-
Patent number: 12162939Abstract: Methods are provided to manipulate phagocytosis of cells, including hematopoietic cells, e.g. circulating hematopoietic cells, bone marrow cells, acute leukemia cells, etc.; and solid tumor cells. In some embodiments of the invention the circulating cells are hematopoietic stem cells, or hematopoietic progenitor cells, particularly in a transplantation context, where protection from phagocytosis is desirable. In other embodiments the circulating cells are leukemia cells, particularly acute myeloid leukemia (AML), where increased phagocytosis is desirable.Type: GrantFiled: April 7, 2021Date of Patent: December 10, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Siddhartha Jaiswal, Irving L. Weissman, Ravindra Majeti, Mark P. Chao
-
Patent number: 12165067Abstract: Systems and methods for anomaly detection in accordance with embodiments of the invention are illustrated. One embodiment includes a method for training a system for detecting anomalous samples. The method draws data samples from a data distribution of true samples and an anomaly distribution and draws a latent sample from a latent space. The method further includes steps for training a generator to generate data samples based on the drawn data samples and the latent sample, and training a cyclic discriminator to distinguish between true data samples and reconstructed samples. A reconstructed sample is generated by the generator based on an encoding of a data sample. The method identifies a set of one or more true pairs, a set of one or more anomalous pairs, and a set of one or more generated pairs. The method trains a joint discriminator to distinguish true pairs from anomalous and generated pairs.Type: GrantFiled: June 25, 2020Date of Patent: December 10, 2024Assignees: The Board of Trustees of the Leland Stanford Junior University, Ford Global Technologies, LLCInventors: Ziyi Yang, Eric Felix Darve, Iman Soltani Bozchalooi
-
Patent number: 12161890Abstract: Provided are antibodies or antigen binding portions thereof that specifically bind Dengue virus, various compositions of such antibodies or antigen binding portions thereof, and methods of their use. Provided are such antibodies, fragments of such antibodies retaining Dengue virus-binding ability, pharmaceutical compositions including such antibodies or antigen binding fragments thereof, and diagnostic compositions including such antibodies or antigen binding fragments thereof. Also provided are isolated nucleic acids encoding such antibodies, amino acid sequences of such antibodies, and host cells transformed therewith. Additionally, provided are prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the disclosure.Type: GrantFiled: August 7, 2019Date of Patent: December 10, 2024Assignees: CZ Biohub SF, LLC, The Board of Trustees of the Leland Stanford Junior UniversityInventors: Fabio Zanini, Derek Croote, Makeda L. Robinson, Leslie Goo, Stephen R. Quake, Shirit Einav, Krista McCutcheon, Eric Waltari
-
Publication number: 20240404619Abstract: Systems and methods for molecular simulation in accordance with embodiments of the invention are illustrated. One embodiment includes a method for predicting a relationship between a ligand and a receptor. The method includes steps for identifying a plurality of conformations of a receptor, computing docking scores for each of the plurality of conformations and a set of one or more ligands, and predicting a relationship between the set of one or more ligands and the plurality of conformations of the receptor.Type: ApplicationFiled: August 12, 2024Publication date: December 5, 2024Applicant: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Evan Nathaniel Feinberg, Vijay Satyanand Pande
-
Publication number: 20240401134Abstract: Among the various aspects of the present disclosure is the provision of methods and systems for detecting cell states in a biological sample. An aspect of the present disclosure provides for a method of determining cell type or cell states. In some embodiments, the method comprises providing or having been provided a sample comprising DNA or RNA and generating a methylation profile for the DNA or RNA in the sample or providing or having been provided a methylation profile of the DNA or RNA in the sample.Type: ApplicationFiled: October 18, 2020Publication date: December 5, 2024Applicants: Washington University, The Board Of Trustees Of The Leland Stanford Junior UniversityInventors: Aadel Chaudhuri, Irfan Alahi, Aaron Newman
-
Publication number: 20240401034Abstract: Provided herein are methods for inducing CRISPR/Cas-based gene regulation (e.g., genome editing or gene expression) of a target nucleic acid (e.g., target DNA or target RNA) in a cell. The methods include using modified single guide RNAs (sgRNAs) that enhance gene regulation of the target nucleic acid in a primary cell for use in ex vivo therapy or in a cell in a subject for use in in vivo therapy. Additionally, provided herein are methods for preventing or treating a genetic disease in a subject by administering a sufficient amount of a modified sgRNA to correct a mutation in a target gene associated with the genetic disease.Type: ApplicationFiled: January 9, 2024Publication date: December 5, 2024Applicants: The Board of Trustees of the Leland Stanford Junior University, Agilent Technologies, Inc.Inventors: Matthew H. Porteus, Ayal Hendel, Joe Clark, Rasmus O. Bak, Daniel E. Ryan, Douglas J. Dellinger, Robert Kaiser, Joel Myerson
-
Publication number: 20240389857Abstract: A minimally invasive device, containing a pressure channel, camera, and optical fiber imaging probe, to measure the stiffness of tissues in vivo and ex vivo is disclosed. The device is inserted into a patient and navigated to a tissue of interest, where stiffness is evaluated by applying suction and measuring the elongation or by applying compression force and measuring the compression of the tissue. Biopsies can be taken for further analysis, or tissue can be removed using an ablation laser. Small fluorescent molecules or therapeutics can also be delivered for improved visualization and targeted treatment. As such, this technology may be used to evaluate the stiffness of biomaterials as well as tissues and organs that are difficult to access, allowing for simultaneous diagnosis, treatment, and excision of diseased tissues.Type: ApplicationFiled: September 29, 2022Publication date: November 28, 2024Applicants: The Trustees of the Stevens Institute of Technology, Vanderbilt University, The Trustees of Columbia University in the City of New York, The Board of Trustees of the Leland Stanford Junior UniversityInventors: Jinho Kim, Gordana Vunjak-NovaKovic, John D. O'Neill, Meghan Pinezich, Brandon A. Guenthart, Seyed Mohammad Mir, Jiawen Chen, Matthew Bacchetta
-
Publication number: 20240393322Abstract: The present disclosure provides methods for detecting heavy metals in tissues and cells while identifying cell types at the single-cell level with intracellular or cell surface heavy metal content. The cell type can be identified by contacting the cell with an antibody that binds a biomarker conjugated to a heavy metal that is different from the heavy metal detected in or on the surface of the cell. The methods include detecting heavy metals using mass cytometry.Type: ApplicationFiled: September 22, 2022Publication date: November 28, 2024Applicant: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Mary PRUNICKI, Kari C. NADEAU, Eric M. SMITH
-
Patent number: 12151103Abstract: Systems and methods for artificial sight in accordance with embodiments of the invention are illustrated. One embodiment includes a retinal prosthesis system including an external controller, a scene imager, an eye imager, an implanted controller, and a stimulation interface in communication with the implanted controller, where the stimulation interface is positioned to stimulate a plurality of retinal ganglion cells (RGCs) of the eye, where the external controller is configured to obtain image data describing a scene from the scene imager, obtain eye position data from the eye imager, determine a field of view (FOV) in the scene based on the eye position data; where the implanted controller is configured to obtain the FOV from the external controller, continuously select stimulation pulses from a dictionary based on the FOV, and stimulate the plurality of RGCs using the stimulation interface in accordance with the selected stimulation pulses.Type: GrantFiled: March 23, 2020Date of Patent: November 26, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Nishal Pradeepkumar Shah, Eduardo Jose Chichilnisky
-
Patent number: 12155227Abstract: In certain examples, methods and semiconductor structures are directed to an apparatus including source circuitry configured to provide power to other circuitry, with the source circuitry including amplification circuitry (e.g., with a power-switching output) and a source resonator. The amplification circuitry is to provide power to the source resonator with a gain that is dependent on a coupling rate between the source circuitry and other external-receiving circuitry. The source circuitry is also to offset phase delay caused by the amplifier. In operation, the source resonator generates a magnetic field in response to the power, for highly-efficient wirelessly transfer of the power to the other circuitry.Type: GrantFiled: October 23, 2020Date of Patent: November 26, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Sid Assawaworrarit, Shanhui Fan
-
Patent number: 12153111Abstract: A method for magnetic resonance imaging performs chemical shift encoded imaging to produce complex dual-echo images which are then applied (with imaging parameters) as input to a deep neural network to produce as output water-only and fat-only images. The deep neural network can be trained with ground truth water/fat images derived from chemical shift encoded images using a conventional water-fat separation algorithm such as projected power approach, IDEAL, or VARPRO. The chemical shift encoded imaging comprises performing an image acquisition with the MRI scanner via a spoiled-gradient echo sequence or a spin-echo sequence.Type: GrantFiled: January 27, 2023Date of Patent: November 26, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Shreyas S. Vasanawala, Yan Wu
-
Patent number: 12150777Abstract: Provided herein are, inter alia, methods for identifying subjects suffering from depression that will respond to treatment with an antidepressant.Type: GrantFiled: March 15, 2019Date of Patent: November 26, 2024Assignees: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSInventors: Amit Etkin, Yu Zhang, Greg Fonzo, Madhukar Trivedi
-
Publication number: 20240382528Abstract: The present disclosure provides methods and compositions for genetically modifying hematopoietic stem and progenitor cells (HSPCs), in particular by correcting a JAK2V617F mutation in the HSPCs.Type: ApplicationFiled: October 4, 2022Publication date: November 21, 2024Applicant: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Matthew H. Porteus, Michael Kyle Cromer
-
Patent number: 12144862Abstract: Polyacrylamide-based copolymers act as stabilizing excipients in formulations of antibody biopharmaceutical agents without interacting directly with the antibody or altering its pharmacokinetic properties. The polyacrylamide-based copolymers confer a substantial stability benefit to high concentration compositions of a variety of antibodies by precluding adsorption of the antibody to the interfaces of the composition, preventing undesirable aggregation events and maintaining the binding activity of the antibody. Such antibody compositions are useful in methods of administering the composition to a subject.Type: GrantFiled: May 23, 2023Date of Patent: November 19, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Eric A. Appel, Joseph L. Mann, John Klich, Catherine M. Kasse
-
Patent number: 12146826Abstract: A device for detecting optical chirality includes a metasurface composed of a biperiodic array of nanodisks in the form of a checkerboard array [300], where the nanodisks have diameters d±?/2 such that adjacent nanodisks [302, 304] have diameters that differ by an offset ?. The nanodisks are composed of a dielectric material that is transparent and has a refractive index greater than 2 at a predetermined operational ultraviolet wavelength. The nanodisks have a width-to-height aspect ratio d/h tuned to produce spectral overlap of electric dipole and magnetic dipole modes of incident circularly polarized ultraviolet light.Type: GrantFiled: November 8, 2020Date of Patent: November 19, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Jennifer A. Dionne, Jack Hu, Michelle Solomon, Mark Lawrence
-
Publication number: 20240378432Abstract: Systems, methods, and other embodiments described herein relate to specialized hardware accelerators for deep learning tasks. In one embodiment, a system includes a first waveguide and a second waveguide. The first waveguide is spaced from the second waveguide. The system includes a first phase tuning component, a second phase tuning component, and a signal mixing component. The first phase tuning component includes a first ring resonator that is coupled to the first waveguide. The second phase tuning component includes a second ring resonator that is coupled to the second waveguide. The signal mixing component includes at least a third ring resonator and a fourth ring resonator. The third ring resonator is coupled to the first waveguide and the fourth ring resonator is coupled to the second waveguide. Further, the third ring resonator and the fourth ring resonator are coupled to each other.Type: ApplicationFiled: May 11, 2023Publication date: November 14, 2024Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., The Board of Trustees of the Leland Stanford Junior University, Toyota Jidosha Kabushiki KaishaInventors: Jiahui Wang, Shanhui Fan, Sean P. Rodrigues, Ercan Mehmet Dede
-
Patent number: 12144100Abstract: A hadron therapy system that provides 3D scanning and rapid delivery of a high dose. Such systems can include a hadron source and accelerator with an RF energy modulator and an RF deflector that operate in combination to provide 3D scanning of a targeted tissue. The systems can include a permanent magnet quadrupole for magnification of the beam. The systems can include high energy hadron sources that utilize a multi-cell, multi-klystron design that achieves scanning of high energy hadron beams, for example a fixed energy of 200 MeV protons. Such systems can provide full irradiation of a liter scale tumor within one second or less.Type: GrantFiled: August 28, 2020Date of Patent: November 12, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Sami G. Tantawi, Emilio Nanni, Zenghai Li, Cecile Limborg-Deprey
-
Patent number: 12139749Abstract: Methods and apparatus for direct detection of chemical reactions are provided. Electric charge perturbations of the local environment during enzyme-catalyzed reactions are sensed by an electrode system with an immobilized target molecule. The charge perturbation caused by the polymerase reaction can uniquely identify a DNA sequence. The polymerization process generates local perturbations of charge in the solution near the electrode surface and induces a charge in a polarazible gold electrode. This event is detected as a transient current by a voltage clamp amplifier. Detection of single nucleotides in a sequence can be determined by dispensing individual dNTPs to the electrode solution and detecting the charge perturbations. Alternatively, multiple bases can be determined at the same time using a mix of all dNTPs with subsequent analysis of the resulting signal.Type: GrantFiled: November 2, 2020Date of Patent: November 12, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Nader Pourmand, Miloslav Karhanek, Ronald W. Davis